Association between thyroid-stimulating immunoglobulin levels and ocular findings in pediatric patients with Graves disease

Transactions of the American Ophthalmological Society

Volumn 105, Issue , 2007, Pages 146-150

  Acuna, Olga M ^a   Athannassaki, Ioanna ^b   Paysse, Evelyn A ^a,b  

^a CULLEN EYE INSTITUTE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID STIMULATING IMMUNOGLOBULIN;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENDOCRINE OPHTHALMOPATHY; EXOPHTHALMOS; EYE MOVEMENT DISORDER; EYELID DISEASE; FEMALE; FOLLOW UP; GRAVES DISEASE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; KERATITIS; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; FEMALE; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; IMMUNOGLOBULINS; MALE; RECEPTORS, THYROTROPIN; RETROSPECTIVE STUDIES; THYROTROPIN;

EID: 47749146838     PISSN: None     EISSN: 15456110     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Graves R. Clinical lectures (part II). London Med Surg J 1835;7:516-517.
2. Uretsky SH, Kennerdell JS, Gutai JP. Graves' ophthalmopathy in childhood and adolescence. Arch Ophthalmol 1980;98:1963-1964.
3. Chan W, Wong GW, Fan DS, et al. Ophthalmopathy in childhood Graves' disease. Br J Ophthalmol 2002;86:740-742.
4. Heufelder AE. Involvement of the orbital fibroblast and TSH receptor in the pathogenesis of Graves' ophthalmopathy. Thyroid 1995;5:331-340.
5. Paschke R, Vassart G, Ludgate M. Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid associated ophthalmopathy. Clin Endocrinol (Oxf) 1995;42:565-569.
6. Crisp MS, Lane C, Halliwell M, Wynford-Thomas D, Ludgate M. Thyrotropin receptor transcripts in human adipose tissue. J Clin Endocrinol Metab 1997;82:2003-2005.
7. Gupta MK. Thyrotropin receptor antibodies: advances and importance of detection techniques in thyroid diseases. Clin Biochem 1992;25:193-199.
8. Orgiazzi J. Anti-TSH receptor antibodies in clinical practice. Endocrinol Metab Clin North Am 2000;29:339-355, vii.
9. Perrild H, Lavard L, Brock-Jacobsen B. Clinical aspects and treatment of juvenile Graves' disease. Exp Clin Endocrinol Diabetes 1997;105 Suppl 4:55-57.
10. Wong GW, Cheng PS. Increasing incidence of childhood Graves' disease in Hong Kong: a follow-up study. Clin Endocrinol (Oxf) 2001;54:547-550.
11. Bartley GB, Fatourechi V, Kadrmas EF, et al. Chronology of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol 1996;121:426-434.
12. Young LA. Dysthyroid ophthalmopathy in children. J Pediatr Ophthalmol Strabismus 1979;16:105-107.
13. Bahn RS. Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy. Thyroid 2002;12:193-195.
14. Saravanan P, Dayan CM. Thyroid autoantibodies. Endocrinol Metab Clin North Am 2001;30:315-337, viii.
15. Costagliola S, Many MC, Denef JF, Pohlenz J, Refetoff S, Vassart G. Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease. J Clin Invest 2000;105:803-811.
16. Dragan LR, Seiff SR, Lee DC. Longitudinal correlation of thyroid-stimulating immunoglobulin with clinical activity of disease in thyroid-associated orbitopathy. Ophthal Plast Reconstr Surg 2006;22:13-19.
17. Kazuo K, Fujikado T, Ohmi G, Hosohata J, Tano Y. Value of thyroid stimulating antibody in the diagnosis of thyroid associated ophthalmopathy of euthyroid patients. Br J Ophthalmol 1997;81:1080-1083.
18. Gerding MN, van der Meer JW, Broenink M, Bakker O, Wiersinga WM, Prummel MF. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clin Endocrinol (Oxf) 2000;52:267-271.
19. Shibayama K, Ohyama Y, Yokota Y, Ohtsu S, Takubo N, Matsuura N. Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease. Endocr J 2005;52:505-510.
20. Khoo DH, Ho SC, Seah LL, et al. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy. Thyroid 1999;9:1175-1180.
21. Durairaj VD, Bartley GB, Garrity JA. Clinical features and treatment of graves ophthalmopathy in pediatric patients. Ophthal Plast Reconstr Surg 2006;22:7-12.